On the other hand, Kinin-kallikrein and renin-angiotensin systems, through B1, B2 and AT2 receptors, potentiates paclitaxel-associated acute pain syndrome (P-APS) in mice. This evidence concerns the gene KLK4 and autoimmune polyendocrinopathy.